HLI - Houlihan Lokey, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$159.80
DETAILS
HIGH:
$187.00
LOW:
$145.00
MEDIAN:
$154.00
CONSENSUS:
$159.80
UPSIDE:
22.26%
AlphaVal
Deterministic, archetype-aware fair value
Banks, Insurers & Asset Managers
85% confidence
Primary model: P/Tangible Book × ROE Quality
Adjust Assumptions
57.3%
9.8%
Key Value Driver
ROTCE (57.3%) vs. cost of equity (9.8%)
Implied Market Multiple
12.31x
Plain-Language Summary
With ROTCE of 57.3% vs. 9.8% cost of equity, fair P/TBV is 3.60x on $10.62 tangible book, implying $104.76 per share. DDM cross-check: $77.13.
Analyst Consensus (External Reference)
Never blended into the bear/base/bull estimates above -- shown only as an outside comparison.
Average Target (16 analysts)
$159.80
Analyst Range
$145.00 – $187.00
Divergence from AlphaVal
34%
Warnings
Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Dividend-based valuation: $77.13 (26% below our primary estimate). Large gaps suggest the dividend may not fully reflect the company's value.
Wall Street's average price target is $159.80 (from 16 analysts). Our estimate is 34% below the consensus -- consider that gap carefully.
Key Risks
- Book value quality matters as much as level — check loan loss reserves
- Interest rate sensitivity creates non-linear earnings surprises
- Insurance reserving is actuarial, not financial — errors emerge slowly